Biotech Issuers Face Pricing Pressure in November

by Elizabeth Krutoholow


Health-care IPOs hit some market resistance last month. In November, seven biotech companies postponed their initial public offerings citing poor market conditions. According to Bloomberg data, other offerings have not been postponed in 2013 prior to November and only four have been withdrawn.


Read more >>>

Bloomberg BRIEF Newsletters